Predicted coronary risk for adults with coronary heart disease and low HDL-C: An analysis from the US National Health and Nutrition Examination Survey

Current Medical Research and Opinion

Volumn 24, Issue 9, 2008, Pages 2711-2717

  Zhang, Bin ^a   Menzin, Joe ^a   Friedman, Mark ^a   Korn, Jonathan R ^a   Burge, Russel T ^b  

^a Boston Health Economics Inc   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Cholesterol; Coronary disease; Dyslipidemias; HDL; Population; Risk

Indexed keywords

FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; AWARENESS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PREDICTION; PREVALENCE; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY PREVENTION; SELF REPORT; SEX DIFFERENCE; SMOKING HABIT;

AGED; CHOLESTEROL, HDL; CORONARY DISEASE; FEMALE; HUMANS; MALE; NUTRITION SURVEYS; RISK FACTORS; UNITED STATES;

EID: 53349171794     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802363198     Document Type: Article

References (19)

1. Centers for Disease Control and Prevention (CDC). Heart disease facts and statistics. 2008. Available from http://www.cdc.gov/heartdisease/ facts.htm (Last accessed 9 Jul 2008]
2. World Health Organization. The atlas of heart disease and stroke. 2008. Available from http://www.who.int/cardiovascular_diseases/resources/ atlas/en/ [Last accessed 9 Jul 2008]
3. American Heart Association and American Stroke Association. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-146
4. Liu JL, Maniadakis N, Gray A, et al. The economic burden of coronary heart disease in the UK. Heart 2002;88:597-603
5. Curb JD, Abbott RD, Rodriguez BL, et al. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res 2004;45:948-53
6. Sharrett AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001;104:1108-13
7. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15
8. Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) [comment]. BMJ 1998;316:823-8
9. Barter P, Gotto AM, Phil D, et al. HDL cholesterol, very low levels of HDL cholesterol, and cardiovascular events. N Engl J Med 2007;357:1301-10
10. Rubins HB, Robins SJ, Collins D, et al, Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341:410-8
11. D'Agostino RB, Russell MW, et al. Primary and subsequent coronary risk appraisal: new results from The Framingham Study. Am Heart J 2000; 139:272-81
12. National Center for Health Statistics. National health and nutrition examination survey. 2008, Available from http://www.cdc.gov/nchs/ nhanes.htm [Last accessed 9 Jul 2008]
13. National Center for Health Statistics and Centers for Disease Control and Prevention (CDC). The National Health and Nutrition Examination Survey (NHANES) Analytic and reporting guidelines. 2005. Available from http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/ nhanes_analytic_guidelines_dec_2005.pdf [Last accessed 15 April 2008]
14. Assmann G, Schulte H, von Eckardstein A, et al. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996; 124:11-20
15. Strandberg TE, Pitkala KH, Berglind S, et al. Multifactorial intervention to prevent recurrent cardiovascular events in patients 75 years or older: the Drugs and Evidence-Based Medicine in the Elderly (DEBATE) study: a randomized, controlled trial. Am Heart J 2006;152:585-92
16. Munoz MA, Vila J, Cabanero, M, et al. Efficacy of an intensive prevention program in coronary patients in primary care, a randomised clinical trial. Int J Cardiol 2007;118:312-20
17. Robinson JG, Maheshwari N. A 'poty-portfolio' for secondary prevention: a strategy to reduce subsequent events by up to 97% over five years. Am J Cardiol 2005;95:373-8
18. Hyre AD, Muntner P, Menke A, et al. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Am J Epidemiol 2007;17:548-55
19. D'Agostino RB, Sr, Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286:180-7